PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 35 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $15,000 | -79.7% | 153,020 | -23.2% | 0.00% | – |
| Q2 2016 | $74,000 | +39.6% | 199,233 | +43.7% | 0.00% | – |
| Q1 2016 | $53,000 | -63.4% | 138,674 | -62.6% | 0.00% | – |
| Q4 2015 | $145,000 | -73.8% | 370,734 | -61.5% | 0.00% | – |
| Q3 2015 | $553,000 | +4508.3% | 962,020 | +6356.5% | 0.00% | – |
| Q4 2014 | $12,000 | -96.0% | 14,900 | -94.9% | 0.00% | – |
| Q3 2014 | $299,000 | +14.1% | 292,851 | -3.8% | 0.00% | – |
| Q2 2014 | $262,000 | – | 304,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $221,000 | 0.02% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $10,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 1,077,555 | $107,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $8,000 | 0.00% |
| Virtu KCG Holdings LLC | 364,520 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 81,647 | $8,000 | 0.00% |
| WADE G W & INC | 80,000 | $8,000 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 29,358 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,500 | $0 | 0.00% |